NEWLY DIAGNOSED MULTIPLE MYELOMA ELDERLY PATIENTS

Chairmen: Hirokazu Murakami, Paul G. Richardson 

Debate - Change Therapy for High/Low Risk Patients - Yes

S. Vincent Rajkumar

SLIDES

Debate - Change Therapy for High/Low Risk Patients - No

Paul G. Richardson

Conclusions:

-       Apply the best possible treatment at all stages and across the patient spectrum

-       Incorporate novel agents as combinations

-       Challenge clonal heterogeneity and improve outcome

-       Enrol in clinical trials

SLIDES

Optimal Therapy for Fit Elderly Patients

Ruben Niesvizky

The older fit patient, therapeutic considerations:

Is CR/MRD the goal? YES

Is transplant therapy the way? CAN BE

Is continued treatment best? YES

Can novel drugs improve outcome? YES

SLIDES

Optimal Therapy for Unfit Elderly Patients

Sonja Zweegman 

SLIDES